Background. Acupuncture is underutilized as an adjunct cancer therapy. The main study objectives were to determine the feasibility of administering acupuncture as palliative therapy to patients with advanced ovarian or breast cancer and to assess the effect on symptoms and quality of life (QOL). Methods. This study was a pilot, single-armed prospective clinical trial for patients with advanced cancer to receive 12 acupuncture sessions over 8 weeks with follow-up at weeks 9 and 12. Ambulatory patients with advanced ovarian or breast cancer were enrolled to receive treatments at an outpatient academic oncology center. Symptom severity was measured before and after each acupuncture session. A composite QOL assessment tool, consisting of validated instruments, was completed at 5 time points. Results. Forty patients enrolled in the study. Twenty-eight patients (70%; 95% confidence interval [CI] = 53%-83%) completed 4 weeks of treatment, and 26 patients (65%; 95% CI = 48%-79%) completed 8 weeks. Eight patients (20%) withdrew before receiving acupuncture, and 6 patients (15%) discontinued treatment early because of disease progression or scheduling demands. Among all 32 assessed patients, there was self-reported improvement immediately post-treatment in anxiety, fatigue, pain, and depression and significant improvement over time for patients with anxiety (P = .001) and depression (P = .02). Among patients experiencing baseline symptoms, there was improvement in anxiety (P = .001), fatigue (P = .0002), pain (P = .0002), and depression (P = .003). QOL measures of pain severity and interference, physical and psychological distress, life satisfaction, and mood states showed improved scores during treatment, with sustained benefit at 12 weeks. Conclusions. This pilot study demonstrates that an 8-week outpatient acupuncture course is feasible for advanced cancer patients and produces a measurable benefit that should be evaluated in controlled trials.
Introduction
In 2009, the estimated number of new cases of ovarian cancer was 21,550 and estimated deaths were 14,600. 1 Given the difficulties in early detection, women are often not diagnosed until they have reached an advanced stage. 2 Additionally, although chemotherapy is quite effective initially, more than 80% of patients will eventually experience a recurrence of their cancer. In both situations, palliative treatment is the goal. 3 In 2009, the estimated number of new cases of female breast cancer was 192,370 and estimated deaths were 40,170. 1 Although most breast cancer is diagnosed at an early stage and can be cured, a substantial number of individuals are diagnosed at an advanced stage, when palliative rather than curative treatments are currently used. Patients with either advanced ovarian or breast cancer may experience difficult disease and treatment-related symptoms and often struggle with diminished quality of life (QOL). 4, 5 These patients face daily physical, psychological, spiritual, and/or emotional challenges. Though their cancer may be incurable, comprehensive care includes palliative therapies that alleviate symptoms and can improve patients' QOL. Nonpharmacological interventions provided by complementary or integrative therapies, such as acupuncture, may provide some benefit to patients receiving conventional treatment. [6] [7] [8] [9] Cancer patients and survivors have demonstrated a remarkable interest in complementary and alternative medicine (CAM), with reported use in the United States ranging from 34% to 91%, depending on the particular cancer population studied and whether prayer and exercise are included. [10] [11] [12] [13] For clinicians, a lack of familiarity with these modalities and with the relevant evidence-based research, safety concerns, and perhaps skepticism may contribute to the overall low recommendation rates. [14] [15] [16] [17] Among complementary and integrative modalities, acupuncture is relatively less used, despite published evidence of its potential benefits. 18, 19 Cancer patients' use of acupuncture is estimated to be from 1.7% to 31%. [20] [21] [22] In addition to some clinicians' lack of familiarity with this therapy, others may not mention acupuncture because of safety concerns for cancer patients, despite an excellent track record of patient safety. 23 Additionally, a clear, straightforward biological mechanism is not yet understood, though acupuncture is an active field of research interest. 19 Acupuncture's benefit for cancer patients with chemotherapy-induced nausea and vomiting was one of the first uses agreed on at the NIH consensus conference in 1997 24 and has been reconfirmed in other studies. 9, 25 Acupuncture also benefits patients with other cancer-or treatment-related symptoms, such as pain, 7 fatigue, 6, 26, 27 anxiety, 27 and overall well-being. [27] [28] [29] However, the efficacy of acupuncture as an adjunct to palliative chemotherapy is not widely recognized; therefore, it is rarely offered as an adjunct to standard care in the United States. 30 The primary aim of this single-arm clinical trial was to evaluate the feasibility and preliminary effects of acupuncture for patients with advanced ovarian and breast cancer. Secondary aims were to assess the change in symptom severity over time and to assess the utility of select QOL instruments in measuring symptoms in an acupuncture study.
Methods Participants
Patients were recruited from the gynecological and breast oncology programs at 2 academic medical centers: Dana-Farber/Brigham and Women's Cancer Center and Massachusetts General Hospital, in Boston, Massachusetts. Patients signed consent forms approved by the institutional review board. The acupuncture treatments were provided free of charge to study participants; there was no additional financial incentive provided for patient participation.
The eligibility criteria for this trial were the following: evidence of metastatic ovarian cancer or other advanced cancers in which there had been a failure of adjuvant therapy and for which there were no curative options; ambulatory status; use of conventional palliative therapy, including chemotherapy; complaints of pain, nausea, and/or inadequate QOL; age > 21years; no acupuncture in the prior 6 months; platelets > 25 000 cells/mL; absolute neutrophil count > 500 cells/ mL; no history of bleeding disorder; no diagnosis of acute psychosis; Karnofsky performance scale score > 60; and ability to speak and read English. Patients enrolled in other complementary medicine or QOL studies were not eligible.
The target enrollment for the study was 40 patients.
The study was open to enrollment in April 2002 and closed to patient accrual in April 2004, after reaching the target accrual.
Treatment
Patients received 8 weeks of acupuncture, given twice weekly during the first 4 weeks and weekly during the last 4 weeks (total of 12 sessions). For twice weekly acupuncture, the sessions were scheduled at least 1 day apart. All acupuncture treatments were performed on-site at the Leonard P. Zakim Center for Integrative Therapies at Dana-Farber Cancer Institute. Three licensed acupuncturists, all trained in traditional Chinese medicine with at least 10 years clinical experience, administered the treatments. As part of treatment follow-up, patients were not to receive any additional acupuncture until after completion of the study (week 12).
A standard, predetermined acupuncture protocol (SAP) and symptom-specific acupuncture protocols (SSPs) were developed based on commonly used points from the medical literature as well as acupuncturists' experiences and consensus. The acupuncture algorithm used was that all patients received the SAP, and if they were experiencing nausea, pain, fatigue, depression, anxiety. insomnia, constipation, or cough at the time of the session, they also received a SSP of preselected points based on specific symptom(s).
The base protocol consisted of the following 10 acupuncture points at 17 sites: ST-36, SP-6, LI-11, LI-4, LV-3, SP-9, Yintang, GV-20, CV-6, and Shenmen. Point selection under the SSP for each category was made from the following: PC-6, CV-12, ST-37 (nausea); Ashi points (pain); K-3, TW-5, GV-14, LU-9 (fatigue); HT-7, PC-4, LV-5, GV24 (depression/anxiety); GB-20, HT-7, PC-7 (insomnia); ST-25, TW-6, BL-57 (constipation); LU-7, LU-6, LU-10, CV-22, BL13 (cough). A study patient received the full SAP base protocol if there were no specific symptoms. If a patient reported a specific symptom, a minimum of one symptom-specific point from that category would be selected in addition to the SAP. For each additional point used for a specific symptom, an effort was made to deduct the same number of points in the SAP to maintain approximately the same number of acupuncture points for each treatment session. At each session, stainless steel acupuncture needles (Vinco, Helio Medical Supplies, USA) with a size 36 gauge, 1 inch (0.20 mm × 25 mm) were inserted into these points and needles were manually manipulated to obtain a "De Qi" sensation-a mild, dull aching sensation. Each session lasted 30 minutes and occurred in a quiet room with dimmed lights. No electrostimulation was applied.
At each session, data were obtained on the presence and severity of the specific symptoms noted above; "other" symptoms reported by patients were recorded, but not treated. Before each acupuncture session ("pre-session"), the acupuncturist asked the patient whether or not each symptom was present, and if so, recorded the symptom severity (scale of 0-10; 10 = most severe). After the session, the acupuncturist completed a second form to record the post-session symptom severity. The patient's responses were recorded on a standard form. Information about any new medical or complementary treatment initiated since the prior session was also recorded.
Instruments
The QOL assessment tool consisted of individual assessment tools used in other studies involving cancer patients or survivors: the Brief Pain Inventory (BPI), 31, 32 Rotterdam Symptom Checklist (RSCL), 4, 33 Satisfaction With Life Domains Scale-Cancer (SLDS-C), [34] [35] [36] Profile of Mood States (POMS), [37] [38] [39] [40] and Cancer Coping Methods. 41 The questionnaires were completed by patients at 5 time points: baseline before treatment (ranging from 1 week to immediately prior to the first treatment session), weeks 4 and 8 of treatment (30 minutes after completion of the acupuncture session), and weeks 9 and 12 (i.e., 1 week and 4 weeks after the final acupuncture session). Patients were allowed to mail in the questionnaires for the final 2 time points.
Brief Pain Inventory. The BPI consists of 2 subscales that measure (1) the severity of cancer pain (pain severity) and (2) the impact of pain on the patient's functioning (pain interference) in the past 24 hours on a scale from 0 (no pain or no interference) to 10 (highest level). 31, 32 Rotterdam Symptom Checklist. The original RSCL included physical symptom and psychological distress subscales. 4 Stein et al. 33 developed a shorter version that omitted the psychological distress items and added some physical symptom items. The version used here added 3 items to the Physical Symptom Distress Scale (Drowsiness, Weak All Over, and Feel Listless [Washed Out]) and dropped 2 items (Low Back Pain and Burning/Sore Eyes). Respondents were asked to indicate the extent to which they have been bothered by each of 32 symptoms during the past week, using a response format of "not at all" to "very much."
Satisfaction With Life Domains Scale-Cancer. The SLDS-C is a broad measure of QOL that asks respondents to indicate their current satisfaction with 18 different life domains relevant to the QOL of cancer patients. [34] [35] [36] The scale uses a picture response format in which satisfaction is indicated by choosing 1 of 7 faces, ranging from a "terrible" frowning face to a "delighted" smiling face. Items can be evaluated individually and a total score calculated.
Profile of Mood States-Short Form (POMS-SF). The POMS was originally developed to assess transient distinct mood states using ratings of 65 adjectives that were rated on a 5-point scale from "not at all" to "extremely." It was scored using 6 factor-based subscales: Depression-Dejection, Tension-Anxiety, Anger-Hostility, Fatigue-Inertia, Confusion-Bewilderment, and Vigor-Activity. 37 The POMS-SF that was used in this study is a 37-item version of the POMS developed and validated on the responses of cancer patients and that retains the 6 subscales. [38] [39] [40] A seventh score of Total Negative Mood Disturbance is calculated by adding together the first 5 subscales and subtracting the score from the one positively scored subscale, Vigor-Activity.
Cancer Coping Methods. The Cancer Coping Methods instrument used in this study is from the questionnaires included in the American Cancer Society's (ACS's) Studies of Cancer Survivors. 41 The Cancer Coping Methods measure consists of a list of complementary therapies plus the addition of some questions regarding talking with other people, which were included based on what patients listed as "other methods" on pilot tests of the ACS questionnaires. In the version used in the large ACS surveys and in our acupuncture study, we used a shorter 32-item list from the original 44-item list that both omitted methods that were little used and added the items related to talking. 41 
Statistical Methods
For the targeted enrollment of 40 patients, feasibility was defined as 75% of patients completing at least 4 weeks of treatment and/or 50% of patients completing all 8 weeks of treatment. If 30 of 40 patients completed 4 weeks of treatment, the 95% confidence interval (CI) for the true 4-week completion rate would be 58.8% to 87.3%. If 20 patients completed 8 weeks of treatment, the 95% CI for the true 8-week completion rate would be 33.8% to 66.2%. A patient was allowed to miss 1 session of treatment at most and still have completed the treatment protocol.
To determine whether any immediate changes after acupuncture treatment had occurred, difference scores (post-treatment minus pre-treatment) were calculated for each patient at each time point. Means and 95% CIs at each time point were computed. Given that acupuncture typically is administered as a course with cumulative benefit, the effect of acupuncture over time (i.e., the change in symptom severity across sessions) was tested. Two separate longitudinal analyses were done, one based on all assessed patients (because symptoms could occur at any time over the duration of treatment) and another based on patients who were experiencing a symptom just prior to treatment on day 1.
Preacupuncture treatment severity score was modeled as the dependent variable, and week was the independent variable. If there were 2 sessions in a week, the second session was treated as occurring one half week after the first session. A compound symmetry covariance matrix was used, and a likelihood ratio test with 11 degrees of freedom was used to determine whether or not there was a statistically significant change in symptom severity over time.
Exploratory analyses tested differences in mean symptom severity by age at study entry (dichotomized as ≤50 vs > 50 years) and years since diagnosis (dichotomized as <2 vs ≥ 2 years) using 2-sample Student's t tests. To examine whether the longitudinal effect of acupuncture was altered by these characteristics, interaction terms between the characteristic and time were included in the aforementioned repeatedmeasures, mixed-effects models. The interactions between age and session and between years since diagnosis and session were tested individually (i.e., in separate models) to conserve power. However, the tests were anticipated to be underpowered given the sample size of this small pilot study.
For all analyses, a 2-sided significance level of .05 was used. Given that this was an exploratory pilot study, P values were not adjusted for multiple comparisons. Analyses were conducted by statisticians (JM, AK) using SAS V8.2.
QOL Statistical Considerations
Data analysis on patients' QOL was conducted (by CK) in SPSS V13.0 and SAS V8.2. If at least half of the items on an instrument were completed, the total score was imputed using the mean of available items. Descriptive statistics were generated to understand the change in QOL scores across different time points. Similar longitudinal models with the consideration of demographic and medical characteristic differences (e.g., age, disease stage, treatment, etc.) among the study participants were tested to further evaluate the association between acupuncture effects and patient's QOL. Covariance structures with the best-fit statistics were used in the final analyses.
Results Feasibility
Twenty-eight of the 40 enrolled patients (70%; 95% CI for treatment completion rate = 53%-83%) completed at least 4 weeks of acupuncture treatment, and 26 patients (65%; 95% CI = 48%-79%) completed all 8 weeks of treatment. The 8-week completion rate met the feasibility criteria, whereas the 4-week completion rate was slightly lower than anticipated.
A total of 8 patients (20%) withdrew from the study before receiving acupuncture because of disease progression (n = 2) or scheduling difficulties/time commitment (n = 6). Six of 32 patients (15%) began study treatment, but withdrew early because of progressive disease (n = 4) or withdrawal of informed consent (n = 2). Therefore, the overall drop-out rate was 35% (14 of 40 patients). Two acupuncturists administered 99% of the treatments (WL, Zhi Ping Li). Among the 26 patients who completed treatment, 21 completed treatment as scheduled, 4 missed 1 treatment session, and 1 completed all 12 sessions but had her final session 3 weeks later than expected (because of travel). The acupuncture treatments were well-tolerated. No significant side effects or adverse events attributable to acupuncture were observed. Table 1 summarizes baseline patient and disease characteristics for all 40 registered patients. The median age was 52 Seven patients (18%) reported initiating a new form of medical treatment and/or complementary therapy over the course of the 8-week acupuncture treatment. These therapies were evenly divided between conventional therapy (chemotherapy) and CAM therapy (e.g., Chinese herbal mixture); 1 patient began both chemotherapy and vitamins. Table 2 summarizes the symptom severity scores reported at baseline for the 32 patients who received any acupuncture treatment. Of these, 30 patients had at least one baseline symptom, and many patients were experiencing multiple symptoms. The most prevalent baseline symptoms were fatigue, anxiety, and pain, individually or in combination. For most symptoms, the mean severity experienced was at a moderate level (4-5 out of 10), though some patients had higher severity scores of 8 to 10. Two patients were asymptomatic at baseline, but described experiencing decreased QOL and therefore were eligible to participate. There were no significant differences in baseline symptom severity by age.
Baseline Characteristics

Immediate Effects of Acupuncture Treatment
Assessment of change in symptom severity scores (posttreatment score minus pre-treatment score) was made for all assessed patients. There was a significant decrease in severity score at the majority of sessions for anxiety, fatigue, pain, and depression. Additionally, a total of 31 patients (97%) reported, following one or more sessions, that acupuncture helped their overall sense of well-being. Figure 1 shows the mean severity score before and after treatment and over the course of treatment for symptom categories having 13 or more patients affected at baseline. For insomnia, only pre-treatment scores are clinically relevant. For all other symptoms, post-treatment scores were lower than pre-treatment scores across all symptoms and time points, with the exception of depression at weeks 6 and 7. 
Longitudinal Changes in Patients' Symptoms
Quality of Life
QOL questionnaire results generally indicated that acupuncture had a positive impact on patients' QOL. Arithmetic means and standard deviations for the QOL scores are presented in Table 3 . Model means also were generated and tested for differences across time points. Patients had better QOL during the 8-week acupuncture treatment than either before treatment was initiated or shortly after it was stopped. Symptom severity decreased over time from the pre-treatment baseline through the last week of acupuncture treatment (week 8). Symptoms or other qualitative parameters then showed some temporary worsening 1 week later (week 9). However, the results 1 month after acupuncture was completed (week 12) continued to show improvement of QOL compared with baseline values.
Patients' pain severity and pain interference scores were significantly improved by 1.26 (P ≤ .0001) and 1.51 NOTES: a In all, 11 patients had severity scores >0 for the following: diarrhea (2), numbness (2), itching/rash, hot flashes, heart burn, neuropathy in feet, shortness of breath, stiffness, and weakness in arms and hands. Figure 1 . Mean symptom severity scores before and after acupuncture treatments for symptom categories having 13 or more affected patients at baseline among only patients with symptoms just prior to treatment on day 1. Mean severity scores before treatment were generally higher than after treatment. For insomnia, only pre-treatment scores are applicable. Vertical lines represent standard errors; dotted line shows model-based estimate of slope; P values indicate significance of change over time among patients with symptoms just prior to treatment on day 1. Pre-tx = pre-treatment; Post-tx = post-treatment (P = .0006) units, respectively, at week 8 of treatment compared to the baseline data (pain severity at baseline = 2.64; pain interference at baseline = 2.30). The study also revealed that the pain status was better one month after the treatment was stopped compared with the time before treatment was given (pain severity and interference one month after treatment completion were 1.59 and P = .0010, and 1.32 and P = .0055, respectively). We also observed significant reduction in the RSCL physical (PHY) and psychological (PSY) burden by 11.53 units (P ≤ .0001) and 13.95 units (P = .0004) units, respectively, at week 8 compared with baseline data. Lower levels of physical and psychological distress were also reported 1 month after the treatment was completed as compared with the baseline values (PHY P = .0001; PSY P = .0004).
A similar trend of improvement was also observed in the SLDS-C, in which patients reported significantly higher life satisfaction at the completion of the acupuncture treatments (week 8) than either before the first session (14.32, P = .0002) or 1 week after the last treatment (6.52; P = .0013). The improvement in the SLDS-C score 1 month after the treatment versus the baseline was 7.81 units (P = .0071). For the POMS-SF, significant differences were detected for all subscales and for total mood disturbance, except for the Vigor-Activity subscale (P = .73). Patients reported 16.10 (P = .0001) and 18.39 (P ≤ .0001) improvement in their mood state at weeks 8 and 12, respectively, compared with baseline.
Regarding patients' use of various Cancer Coping Methods at baseline, the most frequent choices encompassed talking to family or friends (78%), music (68%), prayer or spiritual practice (65%), and exercise (47%), among other choices (data not shown). Nutritional supplements were used by 59% of patients. Other CAM therapies ranged from 3% to 40%, for hypnosis and meditation, respectively. Only 3 patients (10%) indicated that they had used acupuncture or acupressure as a coping strategy prior to this study.
Discussion
This study reports that acupuncture is a feasible, safe, and well-tolerated intervention for patients with advanced ovarian or breast cancer; therefore, the primary study aim was achieved. There was also a measurable improvement for certain physical symptoms and subjective QOL. Given that acupuncture usually requires successive treatments to be effective, it was important to learn that patients with advanced cancer, who were naïve to acupuncture, could be compliant with scheduling demands in an outpatient setting and could be followed longitudinally.
Studies that have investigated the use of acupuncture for specific symptom management in palliative care patients 30, 42, 43 indicate that acupuncture has not yet had an impact on clinical practice, though efficacy has been demonstrated in 24 of 27 randomized controlled trials. 30 Regarding the potential benefit of acupuncture as adjunct therapy, patients reported positive experiences both during the treatment phase and at the study's completion, as indicated by improved symptom scores recorded by the acupuncturists and patients' QOL scores from a composite self-assessment tool. In general, mean symptom scores were mild to moderate, though some more significant changes occurred pre-treatment to post-treatment or over time for specific patients and symptoms.
For the 8-week treatment duration, measures of QOL showed continued improvement, with sustained improvement at week 12 relative to baseline values. The decrease in QOL scores 1 week after treatment ended, followed by improvement 3 weeks later to levels comparable to the last acupuncture session, could reflect loss of continuity with the practitioner or simply an independent time trend.
There are several limitations to this study. Without a control group in this feasibility study, the significant findings cannot be directly attributed to acupuncture treatments, and all conclusions should be guarded. It is possible that patients improved because of the attentive presence of the acupuncturists, the relaxing environment, patients' desire to please the practitioners, concurrent cancer treatment, placebo effect, or a combination of these factors. It is recognized that expectations of the acupuncture procedure can influence outcome measurements provided by patients in a positive way 44 and may possibly reflect the Hawthorne effect, 45 that is, patients performing better because they are participating in a trial.
From a statistical perspective, caution should be exercised in assessing symptoms and QOL over time. Some of the comparisons were based on fewer than 10 patients and are therefore likely to be underpowered. It is also possible that statistically significant differences arose merely by chance, given the large number of comparisons made. Additionally, although it is reasonable to evaluate the group of patients with symptoms at the beginning of the study, this subset analysis has a small sample size.
Given the positive changes in symptom management and improved QOL for patients that occurred over the duration of this acupuncture study, some considerations for designing future studies are warranted. Performing randomized trials, which include a control arm for standard of care, is fundamentally necessary before any firm conclusions can be drawn about the utility of acupuncture in cancer care. Regarding the acupuncture protocol, a fully standardized protocol would minimize variability versus this protocol, which had some individualization. The choice of standardized versus individualized acupuncture remains an active topic of interest and debate in research studies. The required travel to a single urban clinic and the frequency of sessions were the biggest reported problems for patients. In future studies, to increase enrollment and retention, we could investigate the use of satellite locations and increase patient awareness about the availability and potential benefits of acupuncture. In summary, the results of this pilot study indicate that an 8-week treatment course of acupuncture is feasible for advanced cancer patients. Patients reported positive changes in QOL by validated scales, and specific symptoms showed sustained statistically significant changes, warranting further evaluation in controlled trials.
